Biotech Hangout Past Guests
Almost 60 industry leaders have joined the conversation — from CEOs and investors to journalists and analysts, bringing diverse perspectives on the news, deals, and policies shaping biotech.
Biotech Hangout · Past Guests
59
guests have joined the conversation
Noubar Afeyan
CEO, Flagship Pioneering
Patrick Amstutz
CEO, Molecular Partners
Drew Armstrong
Executive Editor, Endpoints
Madeleine Armstrong
Senior Reporter, ApexOnco
Grace Colon
Board Chair: Aronora, Bloom Science And Emm, Board Member: Voyager Therapeutics, MIT, BIO
Roberto Bellini
Former President & CEO, Bellus Health
Alexis Borisy
Executive Chairperson, EQRX
Jay Bradner
Former President, NIBR
Zachary Brennan
Senior Editor, Endpoints
Jennifer Buell
President & CEO, MiNK Therapeutics
Sally Church
Editor, Biotech Strategy Blog
Josh Cohen
Co-CEO, Amylyx Pharmaceuticals
Yuval Cohen
CEO, Corbus Pharmaceuticals
John Crowley
President & CEO, BIO
Frank David
Founder, Pharmagellan
Allison DeAngelis
Reporter, STAT
Stephen Dilly
CEO, Codexis
Eric Elenko
Chief Innovation Officer, PureTech
John Evans
CEO, Beam Therapeutics
Ami Fadia
Managing Director, Needham & Co.
Adam Feuerstein
Senior Writer, STAT
Simone Fishburn
Editor in Chief, BioCentury
Damian Garde
Reporter at Large, Live and Feature Journalism, STAT
Michael Gilman
CEO, Arrakis Therapeutics
David Grainger
Chief Innovation Officer, Centessa
James L. Gulley
Director, NCI Medical Oncology
Alex Harding
SVP, Remix Therapeutics
Paul Hastings
CEO, Nkarta
Chris Heery
CMO, Arcellx
Bahija Jallal
CEO, Immunocore
Lisa Jarvis
Pharma Columnist, Bloomberg
Kevin Judice
CEO, DICE Therapeutics
Rajiv Kaul
Portfolio Manager, Fidelity
Jeb Keiper
CEO, Nimbus Therapeutics
Jason Kelly
Co-Founder & CEO, Ginkgo Bioworks
Justin Klee
Co-CEO, Amylyx Pharmaceuticals
Peter Kolchinsky
Managing Partner, RA Capital
Neil Kumar
CEO, BridgeBio
Jeremy Levin
Partner, Bessemer Venture Partners
Bruce Levine
Professor, University of Pennsylvania
Mathai Mammen
Former EVP R&D, Johnson & Johnson
Melanie Nallicheri
Former Co-founder, CEO, Director at EQRx
Robert Nelsen
Co-founder, ARCH Venture Partners
Andrew Obenshain
CEO, bluebird bio
Felicia Pagliuca
Founder, Semma
Ethan Perlstein
Founder & CEO, Perlara PBC
Jacob Plieth
Journalist, ApexOnco
Andy Plump
President R&D, Takeda
Jim Porter
CEO, Nuvalent
Umer Raffat
Senior Managing Director, Evercore ISI
Melanie Senior
Writer, Nature Biotechnology
Christi Shaw
CEO, Kite Pharma
Nick Shipley
Chief Advocacy Officer, BIO
Luke Timmerman
Founder, Timmerman Report
Praveen Tipirneni
CEO, Morphic Therapeutic
Eric Tokat
Partner, Centerview Partners
Fyodor Urnov
Scientific Director, IGI
Nathan Vardi
Managing Editor, MarketWatch
Ian Walters
CEO, Portage Bio